Ismut Fitomedika

PT Ismut Fitomedika Indonesia is an Indonesian pharmaceutical company specializing in the research, development, and production of standardized herbal medicines (phytopharmaceuticals). Based in Takalar, South Sulawesi, and founded in 2015, the company focuses on elevating traditional Indonesian remedies to "Fitofarmaka" status—clinically proven botanical drugs validated by the Indonesian National Agency of Drug and Food Control (BPOM). Its flagship product, Ifalmin, is a standardized extract of Channa micropeltes (Toman fish) used to treat hypoalbuminemia and accelerate post-operative wound healing. The company currently manages a portfolio of nine core products targeting various metabolic, infectious, and chronic conditions through evidence-based natural innovations.